scispace - formally typeset
Journal ArticleDOI

Letter: A new consistent chromosomal abnormality in chronic myelogenous leukaemia identified by quinacrine fluorescence and Giemsa staining.

Janet D. Rowley
- 01 Jun 1973 - 
- Vol. 243, Iss: 5405, pp 290-293
TLDR
An unsuspected abnormality in all cells from the nine patients with chronic myelogenous leukaemia has been detected with quinacrine fluorescence and various Giemsa staining techniques, suggesting that there may be a hitherto undetected translocation between the long arm of 22 and thelong arm of 9, producing the 9q+ chromosome.
Abstract
CELLS from nine consecutive patients with chronic myelogenous leukaemia (CML) have been analysed with quinacrine fluorescence and various Giemsa staining techniques. The Philadelphia (Ph1) chromosome in all nine patients represents a deletion of the long arm of chromosome 22 (22q−)1,2. An unsuspected abnormality in all cells from the nine patients has been detected with these new staining techniques. It consists of the addition of dully fluorescing material to the end of the long arm of one chromosome 9 (9q+). In Giemsa-stained preparations, this material appears as an additional faint terminal band in one chromosome 9. The amount of additional material is approximately equal to the amount missing from the Ph1 (22q−) chromosome, suggesting that there may be a hitherto undetected translocation between the long arm of 22 and the long arm of 9, producing the 9q+ chromosome.

read more

Citations
More filters
Journal ArticleDOI

Spectrum of somatic mutation dynamics in chronic myeloid leukemia following tyrosine kinase inhibitor therapy

TL;DR: It is shown that patterns of mutation acquisition, persistence, and clearance vary but have a number of interesting correlations with clinical outcomes, and clinical implications of mutation profiles and dynamics in CML should be interpreted with caution.
Journal ArticleDOI

A non-Smad mechanism of fibroblast activation by transforming growth factor-β via c-Abl and Egr-1: selective modulation by imatinib mesylate

TL;DR: It is reported that when expressed in normal fibroblasts, a constitutively active mutant of Abl that causes chronic myelogenous leukemia (CML) stimulated the expression and transcriptional activity of the early growth response factor 1 (Egr-1) and was identified as a target of inhibition by imatinib.
Journal ArticleDOI

Extremely high and specific activity of DNA enzymes in cells with a Philadelphia chromosome

TL;DR: DNA enzymes with 2'-O-methyl modifications are potentially useful as gene-inactivating agents in the treatment of diseases such as CML.
Journal ArticleDOI

Expression of p210bcr/abl by metallothionein promoter induced T-cell leukemia in transgenic mice

TL;DR: The results suggest that the tumorigenicity of the p210bcr/abl chimeric protein is restricted to the hematopoietic tissues in vivo and that an event enhancing p210a/abl expression contributed a proliferative advantage to hematoietIC precursor cells and eventually developed T-cell leukemia in transgenic mice.
Journal ArticleDOI

Chromosomes and causation of human cancer and leukemia. XXII. Karyotypic changes in malignant melanoma

TL;DR: Detailed karyotypic analysis with G‐ and C‐banding has been performed on cells of four malignant melanomas, finding Chromosome #1 was more frequently involved in aberrations than any other chromosome.
References
More filters
Journal ArticleDOI

New Technique for Distinguishing between Human Chromosomes

TL;DR: It seems probable, therefore, that the darker staining with Giemsa of these regions, after denaturation and annealing, indicates the presence of highly repetitive DNA.
Journal ArticleDOI

Technique for Identifying Y Chromosomes in Human Interphase Nuclei

TL;DR: This work investigated the possibility of positively identifying male nuclei in interphase by virtue of this staining property of the Y chromosome using quinacrine dihydro-chloride.
Journal ArticleDOI

Clinical Implications of Cytogenetic Variants in Chronic Myelocytic Leukemia (CML)

TL;DR: The development of other chromosomal abnormalities in Ph1 positive patients presaged the terminal stage of the disease.
Journal ArticleDOI

Philadelphia-Chromosome-Positive and -Negative Chronic Myelocytic Leukemia

TL;DR: Chromosomal studies were performed on 61 adult patients with "typical chronic myelocytic leukemia" and the Philadelphia (Ph1) chromosome was found in 43 patients, with equal sex distribution a year after diagnosis.
Related Papers (5)